Pyxis Oncology (PYXS) Intangibles (2023 - 2025)

Pyxis Oncology (PYXS) has 3 years of Intangibles data on file, last reported at $2.9 million in Q4 2025.

• Intangibles for Q4 2025 came in at $2.9 million, up 11.62% year-over-year; the trailing twelve-month figure through Dec 2025 was $2.9 million (up 11.62% YoY), and the FY2025 annual result was $2.9 million, up 11.62% from the prior year.
• Intangibles climbed to $2.9 million in Q4 2025 per PYXS's latest filing, from $2.4 million in the prior quarter.
• Over five years, Intangibles peaked at $24.5 million in Q4 2023 and troughed at $2.4 million in Q3 2025.
• A 3-year average of $13.1 million and a median of $12.6 million in 2023 frame the typical range for Intangibles.
• On a YoY basis, Intangibles climbed as much as 11.62% in 2025 and fell as far as 89.69% in 2025.
• A 3-year view of Intangibles shows it stood at $24.5 million in 2023, then tumbled by 89.37% to $2.6 million in 2024, then advanced by 11.62% to $2.9 million in 2025.
• Business Quant data shows PYXS's Intangibles at $2.9 million in Q4 2025, $2.4 million in Q3 2025, and $2.5 million in Q2 2025.